The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer.

Wu, Weilu; Yao, Shucong; Huang, Jiapeng; Qing, Jialin; Shi, Qingmei; Huang, Jianping; Qiu, Xingsheng; Zhuang, Yaqiang

Wu, Weilu; Yao, Shucong; Huang, Jiapeng; Qing, Jialin; Shi, Qingmei; Huang, Jianping; Qiu, Xingsheng; Zhuang, Yaqiang.

Afiliação

Wu W; Department of Breast and Thyroid Surgery, Liuzhou People's Hospital, Guangxi, China.
Yao S; Department of Oral and Maxillofacial Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Huang J; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Qing J; Department of Breast and Thyroid Surgery, Liuzhou People's Hospital, Guangxi, China.
Shi Q; Department of Breast and Thyroid Surgery, Liuzhou People's Hospital, Guangxi, China.
Huang J; Department of Breast and Thyroid Surgery, Liuzhou People's Hospital, Guangxi, China.
Qiu X; Department of Breast and Thyroid Surgery, Liuzhou People's Hospital, Guangxi, China.
Zhuang Y; Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Heliyon ; 9(8): e18779, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37664731

Palavras-chave

Breast cancer; Chemoresistance; Chemotherapy; Cisplatin; ZNF268

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google